- Pagina principale
- Analisi delle app
- PatienTrials
- PatienTrials Vs. AMEERA-5
PatienTrials vs. AMEERA-5 Utilizzo e statistiche
PatienTrials helps pharma companies and clinicians run global clinical trials virtually, more efficiently in a closed community setting over HIPAA & GDPR compliant collaboration platform. PatienTrials aims to improve patient adherence by empowering participants with information on the progress of treatment at their fingertips in a community setting, that promotes self-care. PatienTrials captures high-quality patient generated data through solutions based on instant messaging, HealthKit, AI and bots, is poised to make a positive impact on drug development. Monitored by proprietary AI agent for adverse events, PatienTrials reduces study risk and lowers development costs. Founded in 2016, PatienTrials is the first company to bring clinical trials on to a HIPAA & GDPR compliant instant messaging platform.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
A clinical study app focused on on evaluating the safety and efficacy of Amcenestrant plus palbociclib as first line therapy for patients with ER(+) HER2(-) advanced breast cancer.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
PatienTrialsRanking a confronto con AMEERA-5
Confronta la tendenza di classifica PatienTrials nei ultimi 28 giorni rispetto a AMEERA-5
Rank
Nessun dato disponibile
Classifica PatienTrials vs. AMEERA-5 per paese a confronto
Confronta la tendenza di classifica PatienTrials nei ultimi 28 giorni rispetto a AMEERA-5
Nessun dato da visualizzare
Fai confronti con qualsiasi sito con la nostra prova gratuita
![](https://is1-ssl.mzstatic.com/image/thumb/Purple221/v4/42/13/fe/4213fe18-d5f3-d411-bc08-751bea49dc24/AppIcon-0-0-1x_U007emarketing-0-11-0-85-220.png/175x175bb.jpg)
![](https://is1-ssl.mzstatic.com/image/thumb/Purple116/v4/2b/36/c9/2b36c9e3-cbf4-f1e9-1d92-87e68b982936/AppIcon-0-0-1x_U007emarketing-0-0-0-10-0-0-sRGB-0-0-0-GLES2_U002c0-512MB-85-220-0-0.png/175x175bb.jpg)
15icembre d, 2024